Charles Erlichman
Roswell Park Comprehensive Cancer Center(US)Mayo Clinic(US)Piedmont International University(US)Advanced Animal Diagnostics (United States)(US)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology, Cancer therapeutics and mechanisms, PI3K/AKT/mTOR signaling in cancer, Lung Cancer Treatments and Mutations
Most-Cited Works
- → A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.(1988)506 cited
- → Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)(2018)461 cited
- → Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer(2005)457 cited
- → Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.(1998)415 cited
- → Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study(2010)414 cited
- → A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.(1988)